Lipocine Inc.
LPCN
$3.09
-$0.16-4.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.48M | -4.51M | -5.37M | 8.40K | -4.06M |
| Total Depreciation and Amortization | 61.40K | 55.80K | 48.20K | 41.10K | 33.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.80K | -177.80K | -218.20K | -306.50K | -505.70K |
| Change in Net Operating Assets | 234.70K | -357.20K | -57.90K | -964.30K | -417.20K |
| Cash from Operations | -5.14M | -4.99M | -5.60M | -1.22M | -4.95M |
| Capital Expenditure | -10.00K | -90.10K | -90.10K | -90.10K | -89.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.09M | 5.49M | 5.74M | 2.54M | 4.50M |
| Cash from Investing | 5.08M | 5.40M | 5.65M | 2.45M | 4.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 216.90K | 75.60K | 209.30K | 209.30K | 209.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -5.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 8.10K | 0.00 | 0.00 |
| Cash from Financing | 216.90K | 75.60K | 217.40K | 209.30K | 204.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 158.20K | 490.70K | 273.30K | 1.43M | -329.70K |